Elacestrant
ATC L02BA04 · 5 markets · 9 records
US 2 records · 2 strengths
GB 2 records · 2 strengths
- 345 mgtabletKorserdu 345mg tablets
- 86 mgtabletKorserdu 345mg tablets
ES 2 records · 2 strengths
HK 2 records · 1 strengths
Records without a stated strength · 1 ORSERDU
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 ORSERDU
| Strength / form / release | US | GB | ES | HK | EU |
|---|---|---|---|---|---|
| 345 mg tablet | ORSERDU | Korserdu 345mg tablets | ORSERDU | ||
| 86 mg tablet | ORSERDU | Korserdu 345mg tablets | ORSERDU | ||
unknown | ORSERDU | ORSERDU |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
1 more strength/form rows are recorded only in HK · EU and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en HK · EU que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 HK · EU 有记录（未在本表显示）。 另有 1 個規格/劑型僅在 HK · EU 有記錄（未在本表顯示）。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.